Xiaoyong Chen

Xiaoyong Chen

Auto-generated profile, based on publicly available information

Xiaoyong Chen

College of Food Science, Southwest University, Chongqing, 400715, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
XCXiaoyong Chen
Xiaoyong Chen
RZRuifen Zhang
Ruifen Zhang
YLYizhou Li
Yizhou Li
XLXiong Li
Xiong Li
LIJUN YOULIJUN YOU
LIJUN YOU
KHKseniya Hileuskaya
Kseniya Hileuskaya

6 July 2019 in Food & Function
Verified
Journal Article
Closed access
PDF file
XCXiaoyong Chen
Xiaoyong Chen
XLXiong Li
Xiong Li
XZXiaobo Zhang
Xiaobo Zhang
LIJUN YOULIJUN YOU
LIJUN YOU
PCPeter Cheung
Peter Cheung
Jianbo XiaoJianbo Xiao
Jianbo Xiao
PP (Mw= 20.0 kDa) could effectively regulate glucose and lipid metabolism in diabetic mice, and is composed of Glc, Gal and Ara.

27 December 2022 in Cognitive Robotics
Verified
Journal Article
Open access
CXChen Xiao-Yong
Chen Xiao-Yong
YXYang Bo Xiong
Yang Bo Xiong
ZSZhao Shuai
Zhao Shuai
JDJie Ding
Jie Ding
PSPeng Sun
Peng Sun
GLGan Lin
Gan Lin

1 September 2020 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
YZYang Zhang
Yang Zhang
Hai GuoHai Guo
Hai Guo
LMLi Ma
Li Ma
XCXiaoyong Chen
Xiaoyong Chen
GCGuangdong Chen
Guangdong Chen
Purpose: This study was conducted to determine the expression and prognostic relevance of long intergenic non-protein coding RNA 839 (LINC00839) in osteosarcoma (OS) and to explore the detailed roles of LINC00839 in regulating OS cell activities and the mechanisms responsible for its cancer-promoting activity in OS. Methods: The expression of LINC00839 in OS tissues and cell lines was determined by quantitative reverse transcription–polymerase chain reaction. After LINC00839 knockdown, cell counting kit-8 assay, flow cytometric analysis, transwell migration and invasion assay, and in vivo tumor xenograft assay were used to detect its effects on cellular processes in OS. Bioinformatics analyses were conducted to predict the putative miRNAs that target LINC00839. RNA immunoprecipitation assay, luciferase reporter assay, Western blotting analysis, and rescue assays were conducted to establish a relationship among LINC00839, microRNA-454-3p (miR-454-3p), and cellular mesenchymal to epithelial transition factor (c-Met) in OS. Results: LINC00839 was upregulated in OS tissues and cell lines. OS patients characterized with high LINC00839 expression exhibited shorter overall survival than patients with low LINC00839 expression. LINC00839 knockdown caused a significant reduction in OS cell proliferation, migration, and invasion in vitro. Furthermore, LINC00839 depletion inhibited OS tumor growth in vivo and induced apoptosis. Mechanistically, LINC00839 functions as a competitive endogenous RNA in OS by sponging miR-454-3p. c-Met was confirmed as a direct target gene for miR-454-3p in OS cells and was positively regulated by LINC00839 by competitively binding to miR-454-3p. Conclusion: LINC00839 promoted the oncogenicity of OS by targeting the miR-454-3p/c-Met axis. The LINC00839/miR-454-3p/c-Met network may represent a potential target for OS therapy.

7 March 2025 in Journal of Food Science
Verified
Journal Article
Closed access
LWLina Wu
Lina Wu
DHDandan Huang
Dandan Huang
SWSitong Wang
Sitong Wang
JWJiajing Wang
Jiajing Wang
QGQingxu Guo
Qingxu Guo
XCXiaoyong Chen
Xiaoyong Chen

24 August 2020 in Oncology Letters
Verified
Journal Article
Open access
PDF file
SCShengsong Chen
Shengsong Chen
ZLZhanpeng Lu
Zhanpeng Lu
XCXiaoyong Chen
Xiaoyong Chen
XWXiya Wu
Xiya Wu
HTHongying Tu
Hongying Tu
ZXZuke Xiao
Zuke Xiao
Maternal embryonic leucine zipper kinase (MELK), is an adenosine monophosphate‑activated protein kinase‑related kinase that serves important roles in tumourigenesis in multiple malignant tumours. However, to the best of our knowledge, the effect of MELK in lung adenocarcinoma (LUAD) has not been elucidated. The present study aimed to explore the clinical significance of MELK in the prognosis of LUAD. Data from Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA) and The Cancer Genome Atlas (TCGA) were selected to predict the differential mRNA expression levels of MELK mRNA in LUAD and normal tissues. Subsequently, LUAD and adjacent normal tissue samples were collected from 75 patients with the disease, and immunohistochemistry was used to detect the protein expression of MELK. In addition, the Kaplan‑Meier Plotter database, GEPIA and TCGA were used to verify the effect of MELK expression on clinical prognosis in patients with LUAD. MELK was significantly upregulated in LUAD tissues compared with that in normal tissues based on Oncomine, GEPIA and TCGA data (P<0.05). In addition, the results from immunohistochemistry demonstrated that the MELK protein level in LUAD tissues was significantly higher compared with that in matched normal tissues (P<0.05). Prognostic analysis performed using the Kaplan‑Meier plotter, GEPIA and TCGA suggested that the expression of MELK was negatively associated with the overall survival time of patients with LUAD (P<0.05). In conclusion, MELK was highly expressed in LUAD based on bioinformatics and immunohistochemistry analysis, and increased expression of MELK was associated with a poor patient prognosis. MELK may serve as a potential diagnostic marker and therapeutic target for LUAD.